ConductScience.org, home

Library / Genes

UNG: uracil DNA glycosylase

1 protein, 55 patents, 0 drugs, 0 trials, 2,972 NIH grants and 5,288 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolUNGHGNC
Nameuracil DNA glycosylaseHGNC
NCBI Gene ID7374NCBI Gene
HGNC IDHGNC:12572HGNC
EnsemblENSG00000076248NCBI Gene
AliasesDGU, HIGM4, HIGM5, UDG, UNG1, UNG15, UNG2NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P13051Uracil-DNA glycosylase31324Ensembl, GeneID, HGNCUniProt

Patents 55

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-191063P13051Espacenet
US 12435331 B22025-10-0748P13051Espacenet
JP 2025143260 A2025-10-0114P13051Espacenet
JP 2025143279 A2025-10-0122P13051Espacenet
JP 2025517970 A2025-06-121063P13051Espacenet
JP 2025041661 A2025-03-26163P13051Espacenet
JP 2025032080 A2025-03-1119P13051Espacenet
JP 2024123008 A2024-09-108926P13051Espacenet
JP 2024095696 A2024-07-102P13051Espacenet
JP 2023113627 A2023-08-1648P13051Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2972

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P01CA092584Structural Cell Biology of DNA Repair Machines322,025NIH's project files
P01CA234228APOBEC Mutagenesis in Cancer152,025NIH's project files
P30CA008748Cancer Center Support Grant142,025NIH's project files
P30CA047904Cancer Center Support Grant112,025NIH's project files
T32CA009138Molecular, Genetic and Cellular Targets of Cancer Training Program112,025NIH's project files
P30CA043703Case Comprehensive Cancer Center Support Grant92,025NIH's project files
R35GM118062Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics92,025NIH's project files
RM1HG009490Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease92,025NIH's project files
ZIAAG000723ALZHEIMERS RESEARCH PROJECT: DNA repair dysfunction in neurodegeneration and Alzheimer's Disease92,025NIH's project files
P30CA016058Cancer Center Support Grant82,025NIH's project files

Papers 5288

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42825452PubTator, text miningPubMed
42822300PubTator, text miningPubMed
42821551PubTator, text miningPubMed
42801702PubTator, text miningPubMed
42777467PubTator, text miningPubMed
42758019PubTator, text miningPubMed
42723179PubTator, text miningPubMed
42702856PubTator, text miningPubMed
42661455PubTator, text miningPubMed
42649846PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license